Association of mannose-binding lectin gene polymorphisms with antiphospholipid syndrome, cardiovascular disease and chronic damage in patients with systemic lupus erythematosus

Rheumatology

Volumn 46, Issue 1, 2007, Pages 76-80

  Font, J ^a   Ramos Casals, Manuel ^a   Brito Zeron P ^a   Nardi, N ^a   Ibanez A ^b   Suarez, B ^b   Jimenez S ^b   Tassies D ^b   Garcia Criado A ^b   Ros, E ^b   Sentis J ^b   Reverter, J C ^b   Lozano, F ^b  

^a HOSPITAL CLÍNIC   (Spain)

^b UNIVERSITY OF BARCELONA   (Spain)

Author keywords

Antiphospholipid syndrome; Cardiovascular disease; Genetic polymorphism; Mannose binding lectin; Systemic lupus erythematosus

Indexed keywords

CHOLESTEROL; COMPLEMENT COMPONENT C4; DNA; LOW DENSITY LIPOPROTEIN CHOLESTEROL; MANNOSE BINDING LECTIN;

ADOLESCENT; ADULT; AGED; ANTIPHOSPHOLIPID SYNDROME; ARTICLE; CARDIOVASCULAR DISEASE; CHILD; CHRONIC KIDNEY FAILURE; COMORBIDITY; CONTROLLED STUDY; DISEASE ASSOCIATION; DNA FINGERPRINTING; DNA SEQUENCE; EXON; FEMALE; GENETIC ASSOCIATION; GENETIC POLYMORPHISM; GENETIC SUSCEPTIBILITY; GENETIC VARIABILITY; GENOTYPE; HUMAN; HUMAN CELL; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE ANALYSIS; PATHOGENESIS; PREVALENCE; PRIORITY JOURNAL; PROMOTER REGION; SCORING SYSTEM; SYSTEMIC LUPUS ERYTHEMATOSUS; VALVULAR HEART DISEASE; VASCULITIS;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ANTIPHOSPHOLIPID SYNDROME; CARDIOVASCULAR DISEASES; CHILD; CHRONIC DISEASE; FEMALE; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HUMANS; LUPUS ERYTHEMATOSUS, SYSTEMIC; MALE; MANNOSE-BINDING LECTIN; MIDDLE AGED; POLYMORPHISM, GENETIC;

EID: 33845596640     PISSN: 14620324     EISSN: 14620332     Source Type: Journal    
DOI: 10.1093/rheumatology/kel199     Document Type: Article

References (32)

1. Font J, Cervera R, Ramos-Casals M et al. Clusters of clinical and immunologic features in systemic lupus erythematosus: Analysis of 600 patients from a single center. Semin Arthritis Rheum 2004;33:217-30.
2. Thorburn CM, Ward MM. Hospitalizations for coronary artery disease among patients with systemic lupus erythematosus. Arthritis Rheum 2003;48:2519-23.
3. Cervera R, Khamashta MA, Font J et al. Morbidity and mortality in systemic lupus erythematosus during a 10-year period: A comparison of early and late manifestations in a cohort of 1,000 patients. Medicine 2003;82:299-308.
4. Bruce IN, Urowitz MB, Gladman DD, Ibanez D, Steiner G. Risk factors for coronary heart disease in women with systemic lupus erythematosus: The Toronto Risk Factor Study. Arthritis Rheum 2003;48:3159-67.
5. Best LG, Davidson M, North KE et al. Prospective analysis of mannose-binding lectin genotypes and coronary artery disease in American Indians: The Strong Heart Study. Circulation 2004;109:471-5.
6. Hegele RA, Ban MR, Anderson CM, Spence JD. Infection-susceptibility alleles of mannose-binding lectin are associated with increased carotid plaque area. J Investig Med 2000;48:198-202.
7. Madsen HO, Videm V, Svejgaard A, Svennevig JL, Garred P. Association of mannose-binding- lectin deficiency with severe atherosclerosis. Lancet 1998;352:959-60.
8. Madsen HO, Garred P, Thiel S et al. Interplay between promoter and structural gene variants control basal serum level of mannan-binding protein. J Immunol 1995;155:3013-20.
9. Garred P, Larsen F, Madsen HO, Koch C. Mannose-binding lectin deficiency - revisited. Mol Immunol 2003;40:73-84.
10. Turner MW, Hamvas RM. Mannose-binding lectin: Structure, function, genetics and disease associations. Rev Immunogenet 2000;2:305-22.
11. Øhlenschlaeger T, Garred P, Madsen HO, Jacobsen S. Mannose-binding lectin variant alleles and the risk of arterial thrombosis in systemic lupus erythematosus. N Engl J Med 2004;351:260-7.
12. Hochberg MC. Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 1997;40:1725.
13. Jimenez S, Garcia-Criado MA, Tassies D et al. Preclinical vascular disease in systemic lupus erythematosus and primary antiphospholipid syndrome. Rheumatology 2005;44:756-61.
14. Vitali C, Bencivelli W, Isenberg DA et al. II. Identification of the variables indicative of disease activity and their use in the development of an activity score. The European Consensus Study Group for Disease Activity in SLE. Clin Exp Rheumatol 1992;10:541-7.
15. Gladman D, Ginzler E, Goldsmith C et al. The development and initial validation of the Systemic Lupus International Collaborating Clinics/ American College of Rheumatology damage index for systemic lupus erythematosus. Arthritis Rheum 1996;39:363-9.
16. Mullighan CG, Heatley S, Doherty K et al. Mannose-binding lectin gene polymorphisms are associated with major infection following allogeneic hemopoietic stem cell transplantation. Blood 2002;99:3524-9.
17. Ip WK, Chan SY, Lau CS, Lau YL. Association of systemic lupus erythematosus with promoter polymorphisms of the mannose-binding lectin gene. Arthritis Rheum 1998;41:1663-8.
18. Davies EJ, Snowden N, Hillarby MC et al. Mannose-binding protein gene polymorphism in systemic lupus erythematosus. Arthritis Rheum 1995;38:110-4.
19. Villarreal J, Crosdale D, Ollier W et al. Mannose binding lectin and FcgammaRIIa (CD32) polymorphism in Spanish systemic lupus erythematosus patients. Rheumatology 2001;40:1009-12.
20. Carthy D, Hajeer A, Ollier B et al. Mannose-binding lectin gene polymorphism in Greek systemic lupus erythematosus patients. Br J Rheumatol 1997;36:1238-9.
21. Garred P, Madsen HO, Halberg P et al. Mannose-binding lectin polymorphisms and susceptibility to infection in systemic lupus erythematosus. Arthritis Rheum 1999;42:2145-52.
22. Bultink IEM, Hamann D, Seelen MA et al. Deficiency of mannose-binding lectin is not associated with infections in patients with systemic lupus erythematosus. Ann Rheum Dis 2005;64(Suppl. III):234.
23. Bessant R, Hingorani A, Patel L, MacGregor A, Isenberg DA, Rahman A. Risk of coronary heart disease and stroke in a large British cohort of patients with systemic lupus erythematosus. Rheumatology 2004;43:924-9.
24. Calvo-Alen J, Alarcon GS, Tan F et al. Lack of association between mannose binding lectin (MBL) gene polymorphisms and the development of arterial thrombotic events (ATE) in SLE patients from a multiethnic cohort. Lupus 2005;14:222(abstract).
25. Haurum JS, Thiel S, Haagsman HP, Laursen SB, Larsen B, Jensenius JC. Studies on the carbohydrate-binding characteristics of human pulmonary surfactant-associated protein A and comparison with two other collectins: Mannan-binding protein and conglutinin. Biochem J 1993;293:873-8.
26. Malhotra R, Wormald MR, Rudd PM, Fischer PB, Dwek RA, Sim RB. Glycosylation changes of IgG associated with rheumatoid arthritis can activate complement via the mannose-binding protein. Nat Med 1995;1:237-43.
27. Kilpatrick DC. Phospholipid-binding activity of human mannan-binding lectin. Immunol Lett 1998;61:191-5.
28. Limnell V, Aittoniemi J, Vaarala O et al. Association of mannan-binding lectin deficiency with venous bypass graft occlusions in patients with coronary heart disease. Cardiology 2002;98:123-6.
29. Seelen MA, van der Bijl EA, Trouw LA et al. A role for mannose-binding lectin dysfunction in generation of autoantibodies in systemic lupus erythematosus. Rheumatology 2005;44:111-9.
30. Roos A, Bouwman LH, van Gijlswijk-Janssen DJ, Faber-Krol MC, Stahl GL, Daha MR. Human IgA activates the complement system via the mannan-binding lectin pathway. J Immunol 2001;167:2861-8.
31. Svenungsson E, Gunnarsson I, Fei GZ, Lundberg IE, Klareskog L, Frostegard J. Elevated triglycerides and low levels of high-density lipoprotein as markers of disease activity in association with up-regulation of the tumor necrosis factor alpha/tumor necrosis factor receptor system in systemic lupus erythematosus. Arthritis Rheum 2003;48:2533-40.
32. Esdaile JM, Abrahamowicz M, Grodzicky T et al. Traditional Framingham risk factors fail to fully account for accelerated atherosclerosis in systemic lupus erythematosus. Arthritis Rheum 2001;44:2331-7.